MiMedx Group, Inc. (NASDAQ:MDXG – Get Free Report) CAO William Frank Iv Hulse sold 54,596 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $7.89, for a total value of $430,762.44. Following the completion of the transaction, the chief accounting officer now directly owns 440,178 shares of the company’s stock, valued at approximately $3,473,004.42. The trade was a 11.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
William Frank Iv Hulse also recently made the following trade(s):
- On Monday, March 10th, William Frank Iv Hulse sold 81,446 shares of MiMedx Group stock. The shares were sold at an average price of $7.80, for a total value of $635,278.80.
MiMedx Group Stock Up 0.4 %
NASDAQ MDXG opened at $7.92 on Friday. The stock has a fifty day moving average of $8.45 and a 200-day moving average of $7.82. The stock has a market capitalization of $1.17 billion, a P/E ratio of 14.40 and a beta of 1.97. MiMedx Group, Inc. has a 52 week low of $5.47 and a 52 week high of $10.14. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10.
Institutional Investors Weigh In On MiMedx Group
Hedge funds and other institutional investors have recently made changes to their positions in the company. Principal Financial Group Inc. boosted its position in shares of MiMedx Group by 6.3% in the 3rd quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock worth $328,000 after purchasing an additional 3,292 shares during the last quarter. Entropy Technologies LP bought a new position in shares of MiMedx Group in the 3rd quarter worth $64,000. Aigen Investment Management LP bought a new position in shares of MiMedx Group in the 3rd quarter worth $83,000. Victory Capital Management Inc. boosted its position in shares of MiMedx Group by 2.8% in the 3rd quarter. Victory Capital Management Inc. now owns 142,350 shares of the company’s stock worth $841,000 after purchasing an additional 3,901 shares during the last quarter. Finally, Royce & Associates LP boosted its position in shares of MiMedx Group by 5.3% in the 3rd quarter. Royce & Associates LP now owns 972,853 shares of the company’s stock worth $5,750,000 after purchasing an additional 48,539 shares during the last quarter. 79.15% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $13.00 price target on shares of MiMedx Group in a report on Thursday, February 27th.
View Our Latest Research Report on MDXG
About MiMedx Group
MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.
Featured Stories
- Five stocks we like better than MiMedx Group
- How to Evaluate a Stock Before Buying
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Profitably Trade Stocks at 52-Week Highs
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.